A leading biotechnology company with facilities worldwide, Genzyme Corporation’s core R&D operations are situated on a 50-acre suburban office park in Framingham, Massachusetts. The site consists of 32,468 square meters (8 acres) crossing two city limits and bounded on the north and east sides by wetlands. The existing 14-building Framingham campus employs approximately 2,000 people and represents the company’s largest concentration of employees globally.
ARC’s work for Genzyme in Framingham began in the early 1990s with a series of smaller lab and office renovations and evolved into a master plan to address the company’s growth. Over the years, ARC has continued to update this master plan to reflect not only the availability of new land but also the company’s vision and global needs.
